Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 10/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.33 |
| ▸ | HTR1A | P08908 | 2/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25176293 | 0.92 | DRD2 (0.32) | DRD2DRD3SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL16878781 | 0.89 | DRD2 (0.31) | DRD2DRD3 | |
| SCHEMBL16877514 | 0.89 | — | — | |
| SCHEMBL28741732 | 0.85 | CHRM2 (0.34) | — | |
| SCHEMBL17479092 | 0.84 | CCR5 (0.38) | DRD2DRD3 | |
| SCHEMBL22652946 | 0.84 | — | — | |
| SCHEMBL28175046 | 0.84 | DRD2 (0.31) | DRD2DRD3 | |
| SCHEMBL23745320 | 0.84 | — | — | |
| SCHEMBL16877913 | 0.84 | CCR5 (0.38) | DRD2DRD3 | |
| SCHEMBL516829 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3660069-B1 | FAST CURING EPOXY SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2024-01-03 | — | — | EP | claimed |
| EP-3569630-B1 | FAST CURING EPOXY SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2022-08-03 | — | — | EP | claimed |
| EP-3569629-B1 | FAST CURING EPOXY SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2022-07-06 | — | — | EP | claimed |
| EP-2780384-B2 | IMPROVED POLYURETHANE FOAM COMPOSITION | SOUDAL (BE) | 2020-06-10 | — | — | EP | claimed |
| CN-111234182-A | Fast curing epoxy system | 赢创运营有限公司 | 2020-06-05 | — | — | CN | claimed |
| US-20200172723-A1 | FAST-CURING EPOXY SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2020-06-04 | — | — | US | claimed |
| US-20190352452-A1 | FAST-CURING EPOXY SYSTEMS | EVONIK DEGUSSA GMBH (DE) | 2019-11-21 | — | — | US | claimed |
| US-20190352449-A1 | FAST-CURING EPOXY SYSTEMS | EVONIK DEGUSSA GMBH (DE) | 2019-11-21 | — | — | US | claimed |
| CN-107438650-A | The sealant and the method for curing by Photolatent catalysts of matrix polymer/epoxide based on sulfydryl end-blocking | 凯密特尔有限责任公司 | 2017-12-05 | — | — | CN | claimed |
| EP-2780384-B1 | IMPROVED POLYURETHANE FOAM COMPOSITION | SOUDAL (BE) | 2017-08-02 | — | — | EP | claimed |
| CN-1656073-A | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | NOVARTIS AG (CH) | 2005-08-17 | — | — | CN | claimed |
| EP-3660069-B1 | FAST CURING EPOXY SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023141825-A1 | APPLICATION OF TUNG OIL IN POLYURETHANE COMPOSITION | SIKA技术股份公司 | 2023-08-03 | — | — | WO | disclosed |
| US-11524966-B1 | Carboxamides as ubiquitin-specific protease inhibitors | VALO HEALTH, INC. (US) | 2022-12-13 | — | — | US | disclosed |
| EP-3569630-B1 | FAST CURING EPOXY SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2022-08-03 | — | — | EP | disclosed |
| CN-107108829-A | The reduction of aldehyde in amine catalyst | 亨斯迈石油化学有限责任公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-107001878-A | It is used as adhesion promoter or the silicol of crosslinking agent | SIKA技术股份公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106232668-A | There is low monomeric diisocyanate content and the polyurethane-hot melt adhesive of good crosslinking rate | SIKA技术股份公司 | 2016-12-14 | — | — | CN | disclosed |
| US-20150259582-A1 | POLYOL COMPOSITIONS FOR HOT MELT ADHESIVES | IFS Industries Inc. | 2015-09-17 | — | — | US | disclosed |
| US-4299957-A | REACTING N-(2-HYDROXYETHYL)MORPHOLINE WITH EXCESS OF METHANOL IN PRESENCE OF A SILICA-ALUMINUM CATALYST | TEXACO INC. (US) | 1981-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11524966-B1 | Carboxamides as ubiquitin-specific protease inhibitors | USP28, USP25, USP24 | DRD2 4467/4885DRD3 4307/4885MEN1 3554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.